Article
Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
The Journal of thoracic and cardiovascular surgery - 1 Feb 1994
Bongiorno P F, Whyte R I, Lesser E J, Moore J H, Orringer M B, Beer D G
Abstract excerpt
The development of human adenocarcinoma of the lung involves multiple genetic changes including activation of oncogenes and loss of tumor suppressor genes. Patients whose lung tumors contain K-ras oncogene mutation, accumulation of the protein product of the tumor suppressor gene p53, or erbB-2/neu oncoprotein overexpression have been shown to have a worse prognosis. We examined these three genetic indicators in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
